HRX215
Product Specifications
CAS Number
2369583-33-3
Synonyms
Darizmetinib
Target
P38 MAPK
Applications
MAPK
Molecular Formula
C21H17F2N5O3S
Additionnal Information
HRX215 (Darizmetinib) is a first-in-class, highly potent, selective, and orally active inhibitor of MKK4 with an IC50 of 0.02 μM. It enhances liver regeneration, prevents liver failure following extensive hepatectomy in pigs, and has potential to prevent liver failure after major oncological liver resections or transplantation of small liver grafts in humans.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
orb1655742-01 48 Tests
Human Activity-dependent neuroprotector homeobox protein (ADNP) ELISA Kit
Sign In for Pricing
View Details orb1655742-02 96 Tests
Human Activity-dependent neuroprotector homeobox protein (ADNP) ELISA Kit
Sign In for Pricing
View Details 
GTR15114739 1 Vial
Lentiviral human AURKC shRNA (UAS) - Lentiviral human AURKC shRNA (UAS) plasmid
Sign In for Pricing
View Details 
029437-ML490 100 µL
CD62L (L-selectin, CD62 Antigen-like Family Member L, Leukocyte Adhesion Molecule 1, LAM-1, Leukocyte Surface Antigen Leu-8, Leukocyte-endothelial Cell Adhesion Molecule 1, LECAM1, Lymph Node Homing Receptor, TQ1, gp90-MEL, CD62L, SELL, LNHR, LYAM1) (MaxLight 490) discontinued
Sign In for Pricing
View Details